1. Home
  2. LTRY vs CYCN Comparison

LTRY vs CYCN Comparison

Compare LTRY & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LTRY
  • CYCN
  • Stock Information
  • Founded
  • LTRY 2015
  • CYCN N/A
  • Country
  • LTRY United States
  • CYCN United States
  • Employees
  • LTRY N/A
  • CYCN N/A
  • Industry
  • LTRY Computer Software: Prepackaged Software
  • CYCN Biotechnology: Pharmaceutical Preparations
  • Sector
  • LTRY Technology
  • CYCN Health Care
  • Exchange
  • LTRY Nasdaq
  • CYCN Nasdaq
  • Market Cap
  • LTRY 8.8M
  • CYCN 7.8M
  • IPO Year
  • LTRY N/A
  • CYCN N/A
  • Fundamental
  • Price
  • LTRY $1.76
  • CYCN $2.92
  • Analyst Decision
  • LTRY
  • CYCN
  • Analyst Count
  • LTRY 0
  • CYCN 0
  • Target Price
  • LTRY N/A
  • CYCN N/A
  • AVG Volume (30 Days)
  • LTRY 286.6K
  • CYCN 10.9K
  • Earning Date
  • LTRY 08-20-2024
  • CYCN 07-26-2024
  • Dividend Yield
  • LTRY N/A
  • CYCN N/A
  • EPS Growth
  • LTRY N/A
  • CYCN N/A
  • EPS
  • LTRY N/A
  • CYCN N/A
  • Revenue
  • LTRY $6,626,564.00
  • CYCN N/A
  • Revenue This Year
  • LTRY N/A
  • CYCN N/A
  • Revenue Next Year
  • LTRY N/A
  • CYCN N/A
  • P/E Ratio
  • LTRY N/A
  • CYCN N/A
  • Revenue Growth
  • LTRY 75.84
  • CYCN N/A
  • 52 Week Low
  • LTRY $0.82
  • CYCN $1.75
  • 52 Week High
  • LTRY $13.00
  • CYCN $5.25
  • Technical
  • Relative Strength Index (RSI)
  • LTRY 53.35
  • CYCN 55.60
  • Support Level
  • LTRY $0.92
  • CYCN $2.92
  • Resistance Level
  • LTRY $1.74
  • CYCN $3.94
  • Average True Range (ATR)
  • LTRY 0.18
  • CYCN 0.46
  • MACD
  • LTRY 0.08
  • CYCN 0.08
  • Stochastic Oscillator
  • LTRY 52.18
  • CYCN 54.22

About LTRY Lottery.com Inc.

Lottery.com Inc is a leading provider of domestic and international lottery products and services. As an independent third-party lottery game service, the Company offers a platform that it developed and operates to enable the remote purchase of legally sanctioned lottery games in the U.S. and abroad. The Company's revenue-generating activities are focused on (i) offering the Platform via the Lottery.com app and its websites to users located in the U.S. and international jurisdictions where the sale of lottery games is legal and its services are enabled for the remote purchase of legally sanctioned lottery games; (ii) offering an internally developed, created and operated business-to-business application programming interface of the Platform to enable commercial partners in permitted U.S.

About CYCN Cyclerion Therapeutics Inc.

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.

Share on Social Networks: